BioSpace News Archive

Cell Culture Media Market Size to Hit Around USD 16.84 Billion by 2032

A report by Precedence Research examines the cell culture media market size is predicted to hit around USD 16.84 billion by 2032 and is growing at a CAGR of 11.89% from 2023 to 2032.

August 7, 2023
·
7 min read
Business

Shockwave Medical Reports Second Quarter 2023 Financial Results

Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today reported financial results for the three months ended June 30, 2023.

August 7, 2023
·
9 min read
BioMidwest

Myriad Genetics Announces Enhancements to the GeneSight® Test to Personalize Mental Health Medication Treatment Decisions Based on Smoking Status

Myriad Genetics, Inc., a leader in genetic testing and precision medicine, announced enhancements to the GeneSight® Psychotropic test, a pharmacogenomic test for mental health medications.

August 7, 2023
·
4 min read
Business

Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates

Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today reported financial results and provided business updates for the second quarter ended June 30, 2023.

August 7, 2023
·
11 min read
Business

Windtree Therapeutics Reports Second Quarter 2023 Financial Results and Provides Key Business Updates

Windtree Therapeutics, Inc., a biotechnology company focused on advancing late-stage interventions for cardiovascular disorders, reported financial results for the second quarter ended June 30, 2023 and provided key business updates.

August 7, 2023
·
11 min read
BioMidwest

Stryker to participate in the 2023 Wells Fargo Securities Healthcare Conference

Stryker (NYSE:SYK) will participate in the 2023 Wells Fargo Securities Healthcare Conference on Thursday, September 7, 2023.

August 7, 2023
·
1 min read
Business

RxSight, Inc. Reports Second Quarter 2023 Financial Results

RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, reported financial results for the three and six months ended June 30, 2023.

August 7, 2023
·
11 min read
Business

INmune Bio Inc. Announces Second Quarter 2023 Results and Provides Business UpdateCompany to Host Conference Call Today, August 7, at 4:30pm ET

INmune Bio Inc., a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, announces its financial results for the quarter ended June 30, 2023 and provides a business update.

August 7, 2023
·
15 min read
Business

Cara Therapeutics Reports Second Quarter 2023 Financial Results

Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced financial results and operational highlights for the second quarter ended June 30, 2023.

August 7, 2023
·
11 min read
Business

Diane M. Bryant Joins Haemonetics’ Board of Directors

Haemonetics Corporation, a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, has announced the election of Diane M. Bryant to its Board of Directors.

August 7, 2023
·
2 min read